Tactile Systems Technology (TCMD) Shareholder's Equity Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Tactile Systems Technology | 539.21 Mn | 449.02 Mn | 57.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.95% |
| Dec 31, 2025 | 1.06% |
| Sep 30, 2025 | -1.42% |
| Jun 30, 2025 | -2.87% |
| Mar 31, 2025 | 6.28% |
| Dec 31, 2024 | 11.85% |
| Sep 30, 2024 | 13.71% |
| Jun 30, 2024 | 26.40% |
| Mar 31, 2024 | 23.89% |
| Dec 31, 2023 | 59.51% |
| Sep 30, 2023 | 59.82% |
| Jun 30, 2023 | 39.12% |
| Mar 31, 2023 | 35.82% |
| Dec 31, 2022 | -5.32% |
| Sep 30, 2022 | -13.41% |
| Jun 30, 2022 | -14.01% |
| Mar 31, 2022 | -8.11% |
| Dec 31, 2021 | 2.79% |
| Sep 30, 2021 | 21.07% |
| Jun 30, 2021 | 28.37% |
| Mar 31, 2021 | 10.69% |
| Dec 31, 2020 | 10.80% |
| Sep 30, 2020 | 4.96% |
| Jun 30, 2020 | 4.42% |
| Mar 31, 2020 | 22.87% |
| Dec 31, 2019 | 26.13% |
| Sep 30, 2019 | 24.63% |
| Jun 30, 2019 | 25.69% |
| Mar 31, 2019 | 25.75% |
| Dec 31, 2018 | 22.65% |
| Sep 30, 2018 | 21.83% |
| Jun 30, 2018 | 19.00% |
| Mar 31, 2018 | 23.65% |
| Dec 31, 2017 | 22.05% |
| Sep 30, 2017 | 22.10% |
| Jun 30, 2017 | 1,147.69% |
| Mar 31, 2017 | 952.61% |
| Dec 31, 2016 | 1,155.74% |
| Sep 30, 2016 | 950.97% |